Inpatient Care - G20

The projected revenue for the Inpatient Care market in G20 countries is expected to reach a staggering US$2.14tn by 2024.
This forecast indicates a promising future for the industry.
Furthermore, an annual growth rate (CAGR 2024-2029) of 3.57% is anticipated, leading to a market volume of US$2.55tn by 2029.
In terms of global comparison, it is worth noting that United States is projected to generate the highest revenue in the Inpatient Care market among the G20 countries.
Specifically, United States is expected to generate approximately US$731.40bn in revenue by 2024.
This substantial figure highlights the dominance of the United States in this market within the G20 countries.
In the inpatient care market, Germany stands out in the G20 with its highly advanced healthcare infrastructure and emphasis on quality patient care.

Key regions: United States, Germany, Brazil, United Kingdom, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Inpatient Care market in G20 countries has been experiencing significant growth in recent years. This can be attributed to various factors such as an increase in the aging population, rising prevalence of chronic diseases, and advancements in medical technology.

Customer preferences: Customers in the Inpatient Care market in G20 countries are increasingly demanding high-quality medical care services. Patients are becoming more informed and educated about their health, which has led to an increase in demand for personalized and patient-centric care. Additionally, customers are seeking more affordable healthcare services due to rising healthcare costs.

Trends in the market: The Inpatient Care market in G20 countries is witnessing a trend towards the adoption of digital health technologies. This is driven by the need to improve patient outcomes and reduce healthcare costs. Telemedicine, electronic medical records, and mobile health applications are some of the digital technologies that are being widely adopted in the market. Another trend is the shift towards value-based care, which focuses on improving patient outcomes and reducing costs. This has led to an increase in the use of bundled payments and pay-for-performance models.

Local special circumstances: China is one of the fastest-growing markets in the Inpatient Care market in G20 countries. The country has been investing heavily in its healthcare infrastructure, which has led to an increase in the number of hospitals and healthcare facilities. Additionally, the country is witnessing a rise in medical tourism, which is driving demand for high-quality medical care services. In India, the Inpatient Care market is dominated by private healthcare providers, which account for over 80% of the market share. The country is witnessing a trend towards the adoption of digital health technologies, which is being driven by the need to improve patient outcomes and reduce healthcare costs.

Underlying macroeconomic factors: The Inpatient Care market in G20 countries is being driven by various macroeconomic factors such as an increase in the aging population, rising prevalence of chronic diseases, and advancements in medical technology. Additionally, the market is being influenced by government policies aimed at improving healthcare access and quality. The increasing burden of healthcare costs is also driving the adoption of value-based care models. The COVID-19 pandemic has also had a significant impact on the market, with an increase in demand for hospitalization and intensive care services. The pandemic has also accelerated the adoption of digital health technologies in the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.